Establishing the 99


Journal

Biochemia medica
ISSN: 1846-7482
Titre abrégé: Biochem Med (Zagreb)
Pays: Croatia
ID NLM: 9610305

Informations de publication

Date de publication:
15 Jun 2019
Historique:
received: 29 01 2019
accepted: 09 03 2019
entrez: 22 6 2019
pubmed: 22 6 2019
medline: 31 8 2019
Statut: ppublish

Résumé

The knowledge of high sensitivity cardiac troponin I (hsTnI) distribution in a reference population is mandatory for its introduction in clinical practice. The aim of this study was to define the Upper Reference Limit (URL) of hsTnI measured by Single Molecule Counting technology (SMC) in an accurately selected reference population. In the study 1140 blood donors were included and selected on the basis of medical history and biomarkers. High sensitivity cardiac troponin I was measured by SMC technology (Clarity, Singulex, Alamed, USA). The 99th percentile was calculated by the non-parametric method according to the Clinical and Laboratory Standard Institute - CLSI C28-A3. The median age was 41 years (IQR: 28 - 50) and 69% were males. The overall 99th percentile was 5 ng/L (90% CI: 4.2 - 5.6). When considering sex-related differences, we found slight differences between the 99th percentile in males and females. Moreover, the 99th percentile trended with age, especially in females. We defined the 99th percentile of hs-cTnI measured by SMC technology in a highly selected healthy population, with only minor differences between males and females. Our findings provide the basic criteria for the reliable interpretation of hsTnI concentrations measured by the SMC technology in clinical settings.

Identifiants

pubmed: 31223265
doi: 10.11613/BM.2019.020901
pii: bm-29-2-020901
pmc: PMC6559611
doi:

Substances chimiques

Troponin I 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

020901

Déclaration de conflit d'intérêts

Potential conflict of interest: None declared.

Références

Clin Chim Acta. 2018 Nov;486:224-231
pubmed: 30110608
Eur J Epidemiol. 2017 Jul;32(7):583-591
pubmed: 28585121
Clin Chem. 2018 Feb;64(2):398-399
pubmed: 29046331
Clin Chem. 2018 Apr;64(4):645-655
pubmed: 29343532
Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):139-148
pubmed: 27574333
Clin Chem Lab Med. 2017 Nov 27;56(1):120-125
pubmed: 28586301
Clin Chem. 2017 Jan;63(1):261-263
pubmed: 27895086
Scand J Clin Lab Invest. 2017 Oct;77(6):428-432
pubmed: 28650717

Auteurs

Luisa Agnello (L)

Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy.

Chiara Bellia (C)

Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy.

Concetta Scazzone (C)

Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy.

Giulia Bivona (G)

Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy.

Giorgia Iacolino (G)

Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy.

Caterina Maria Gambino (CM)

Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy.

Maddalena Muratore (M)

Unit of Trasfusional Medicine, Villa Sofia-Cervello Hospital, Palermo, Italy.

Bruna Lo Sasso (B)

Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy.

Marcello Ciaccio (M)

Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy.
Department of Laboratory Medicine, AOUP "P. Giaccone", Palermo, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH